Medicine News

A New Treatment Approach for Charcot-Marie-Tooth Disease

August 26, 2014

0 Comments

Potential Therapy for Charcot Marie Tooth Disease

A team of scientists from the Department of Neurogenetics at the Max Planck Institute and University Medical Center Göttingen has discovered a new treatment approach for the hereditary neurological disorder Charcot-Marie-Tooth disease type 1A. Charcot-Marie-Tooth disease type 1A is the most common inherited disease affecting the peripheral nervous system. Researchers from the Department of Neurogenetics […]

Continue reading...

Max Planck Researchers Discover New Weapon of the Immune System

August 14, 2014

0 Comments

Scientists Discover New Immune System Weapon

Scientists have identified a previously unknown component of the immune system, discovering that bacterial virulence factors can not only be neutralized by antibodies, but they can also be directly destroyed by them. Max Planck researchers have discovered a completely new way in which the immune system recognizes pathogens. The aryl hydrocarbon receptor has long been […]

Continue reading...

Yale Researchers Discover New Cancer Cell Vulnerability

July 21, 2014

1 Comment

Researchers Discover New Cancer Cell Vulnerability

New research from Yale University found that simultaneous inhibition of both telomerase and p21 inhibited tumor growth in mice. Yale School of Medicine and Yale Cancer Center researchers have uncovered a genetic vulnerability of cancer cells that express telomerase — an enzyme that drives their unchecked growth — and showed that telomerase-expressing cells depend upon […]

Continue reading...

Newly Designed Nanoparticles Can Deliver Three Cancer Drugs at a Time

April 15, 2014

4 Comments

Scientists Develop Nanoparticles that Can Deliver Three Cancer Drugs at a Time

In a newly published study, MIT chemists detail how they designed nanoparticles that can deliver three cancer drugs at a time. Delivering chemotherapy drugs in nanoparticle form could help reduce side effects by targeting the drugs directly to the tumors. In recent years, scientists have developed nanoparticles that deliver one or two chemotherapy drugs, but […]

Continue reading...

Researchers Uncover Mode of Action of New Multiple Sclerosis Drug

April 7, 2014

0 Comments

Researchers Uncover Mode of Action of New Multiple Sclerosis Drug Dimethyl Fumarate

Scientists from the Max Planck Institute and the University of Lübeck have uncovered the mode of action for dimethyl fumarate, a drug that was recently approved in Europe as a basic therapy for multiple sclerosis. Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis. Although […]

Continue reading...

New Retinal Implant Technology Expected to Help Restore Sight

November 6, 2013

0 Comments

Retinal Implants Expected to Restore Sight to the Blind

In an effort to improve retinal implant technology, researchers have developed a new method that uses microsecond pulses, on-chip counter-electrodes, and controlled firing of electrodes to shape the electrical field, which could help people who have lost their sight see more than just light and vague shapes. Researchers at the University of Arizona and University […]

Continue reading...

Stanford Scientists Are Developing a Mini-Microscope to Detect Cancer Cells

October 1, 2013

0 Comments

Scientists Build a Microscope to Detect Cancer Cells

Stanford scientists are developing a mini-microscope to noninvasively detect circulating tumor cells, allowing for earlier interventions. One of the cruelest truths about cancer is that even after you beat the disease, it can still come back to kill you. A tumor growing in the prostate gland, breast, or any other organ can shed cancerous cells […]

Continue reading...

Microbicide Tricks HIV into “Popping” Itself into Oblivion

September 20, 2013

2 Comments

Microbicide Tricks HIV into Popping Itself into Oblivion

Researchers from Drexel University have developed a microbicide that can trick HIV into “popping” itself into oblivion, destroying the virus without harming healthy cells. Pinning down an effective way to combat the spread of the human immunodeficiency virus, the viral precursor to AIDS, has long been a challenge for scientists and physicians, because the virus […]

Continue reading...

Genomic Test Accurately Distinguishes between Viral and Bacterial Infections

September 19, 2013

1 Comment

Genomic Test Accurately Distinguishes between Viral and Bacterial Infections

A new genomic test developed by researchers at Duke University School of Medicine can accurately sort between viral and bacterial infections, possibly helping to limit the overuse of antibiotics and the emergence of bacterial resistance. A blood test developed by researchers at Duke Medicine showed more than 90-percent accuracy in distinguishing between viral and bacterial […]

Continue reading...

Therapeutic Cancer Vaccine Begins Human Clinical Trials

September 6, 2013

2 Comments

Therapeutic Cancer Vaccine Begins Human Clinical Trials

A Phase I clinical trial of an implantable vaccine to treat melanoma has begun. A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer. The effort is the fruit of a new […]

Continue reading...

Experimental Compound Improves Learning and Memory in Mice with Down Syndrome

September 5, 2013

0 Comments

Compound Reverses Down Syndrome Like Learning Deficits in Mice

In a newly published study, scientists detail the development of an experimental compound that reverses Down syndrome-like learning deficits in mice. Researchers at Johns Hopkins and the National Institutes of Health have identified a compound that dramatically bolsters learning and memory when given to mice with a Down syndrome-like condition on the day of birth. […]

Continue reading...

Drug Candidate SR9009 Increases Exercise Endurance

August 21, 2013

2 Comments

Drug Candidate Leads to Improved Endurance

A new drug candidate, SR9009, has been shown to significantly increase exercise endurance in animal models. Researchers believe these findings may lead to better treatments for people suffering from conditions that acutely limit exercise tolerance. An international group of scientists has shown that a drug candidate designed by scientists from the Florida campus of The […]

Continue reading...